Continuous Processing offers substantial benefits over traditional batch processing methodologies, so much so that the US Food and Drug Administration (FDA) now actively supports the development of continuous improvement capabilities.
Done correctly, Continuous Processing offers the potential for enhanced productivity, reduced waste, better regulatory compliance and a reduction in human error.
With that in mind, Pharma IQ Live: Continuous Processing 2022 will be focused on:
Increasing asset utilization by facilitating continuous production
Reducing process variability and supporting real time release through the use of Process Analytical Technologies (PAT)
Enabling predictive maintenance by leveraging real time data to identify issues
Enhancing manufacturing agility and improving scalability to match supply with demand
Manufacturing drugs that are right first time through the use of Quality by Design (QbD)
The browser you are using is not supported that will prevent you from accessing certain features of the website. We want you to have the best possible experience. For this you'll need to use a supported browser and upgrade to the latest version.